Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Absence of somatostatin receptors in psoriatic skin lesions.

× No keyword cloud information.

15 in total

1. Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors.

Authors: J C Reubi; W H Häcki; S W Lamberts
Journal: J Clin Endocrinol Metab Date: 1987-12 Impact factor: 5.958

2. Treatment of severe psoriasis with somatostatin: four years of experience.

Authors: A Venier; C De Simone; L Forni; G Ghirlanda; L Uccioli; F Serri; L Frati
Journal: Arch Dermatol Res Date: 1988 Impact factor: 3.017

3. Inhibition of insulin secretion by somatostatin.

Authors: K G Alberti; N J Christensen; S E Christensen; A P Hansen; J Iversen; K Lundbaek; K Seyer-Hansen; H Orskov
Journal: Lancet Date: 1973-12-08 Impact factor: 79.321

4. Somatostatin treatment of psoriasis.

Authors: J J Guilhou; A Boulanger; G Barneon; P Vic; J Meynadier; J C Tardieu; J Clot
Journal: Arch Dermatol Res Date: 1982 Impact factor: 3.017

5. Epidermal growth factor, somatostatin, and psoriasis.

Authors: G Ghirlanda; L Uccioli; F Perri; L Altomonte; A Bertoli; R Manna; L Frati; A V Greco
Journal: Lancet Date: 1983-01-01 Impact factor: 79.321

6. Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis.

Authors: L B Nanney; C M Stoscheck; M Magid; L E King
Journal: J Invest Dermatol Date: 1986-03 Impact factor: 8.551

7. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status.

Authors: J C Reubi; A M Landolt
Journal: J Clin Endocrinol Metab Date: 1989-04 Impact factor: 5.958

8. Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors.

Authors: J C Reubi; U Horisberger; W Lang; J W Koper; R Braakman; S W Lamberts
Journal: Am J Pathol Date: 1989-02 Impact factor: 4.307

9. Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-995 (sandostatin). I. An open-label pilot study.

Authors: C Camisa; T M O'Dorisio; R F Maceyko; G E Schacht; H S Mekhjian; B A Howe
Journal: Cleve Clin J Med Date: 1990 Jan-Feb Impact factor: 2.321

10. Passage of somatostatin analogue across human and mouse skin.

Authors: C J Weber; D Jicha; S Matz; J Siverly; T O'Dorisio; L Strausberg; J Laurencot; A McLarty; J Norton; M Kazim
Journal: Surgery Date: 1987-12 Impact factor: 3.982